Phenotypic and clinical implications of variants in the dihydropyrimidine dehydrogenase gene-Reference-Cited by-同舟云学术

Phenotypic and clinical implications of variants in the dihydropyrimidine dehydrogenase gene

Published:2016-04 Issue:4 Volume:1862 Page:754-762
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Kuilenburg André B.P. van,Meijer Judith,Tanck Michael W.T.^ORCID,Dobritzsch Doreen,Zoetekouw Lida,Dekkers Lois-Lee,Roelofsen Jeroen,Meinsma Rutger,Wymenga Machteld,Kulik Wim,Büchel Barbara,Hennekam Raoul C.M.,Largiadèr Carlo R.

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference72 articles.

1. Capecitabine as adjuvant treatment for stage III colon cancer;Twelves;N. Engl. J. Med.,2005

2. Systemic therapy for colorectal cancer;Meyerhardt;N. Engl. J. Med.,2005

3. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile;Heggie;Cancer Res.,1987

4. Evaluation of 5-fluorouracil pharmacokinetics in cancer patients with a c.1905+1G>A mutation in DPYD by means of a Bayesian limited sampling strategy;van Kuilenburg;Clin. Pharmacokinet.,2012

5. Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil;van Kuilenburg;Eur. J. Cancer,2004

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study;Pharmaceutics;2024-07-19

2. DPYD genetic polymorphisms in non-European patients with severe fluoropyrimidine-related toxicity: a systematic review;British Journal of Cancer;2024-06-17

3. Phenotype versus genotype to optimize cancer dosing in the clinical setting—focus on 5‐fluorouracil and tyrosine kinase inhibitors;Pharmacology Research & Perspectives;2024-03

4. Genotyping of <i>UGT1A1</i> and <i>DPYD</i> polymorphisms in patients with colorectal cancer. A review;Journal of Modern Oncology;2024-02-21

5. Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis;British Journal of Cancer;2024-01-15